Back to Search Start Over

Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.

Authors :
Gupta Y
Friedman DJ
McNulty MT
Khan A
Lane B
Wang C
Ke J
Jin G
Wooden B
Knob AL
Lim TY
Appel GB
Huggins K
Liu L
Mitrotti A
Stangl MC
Bomback A
Westland R
Bodria M
Marasa M
Shang N
Cohen DJ
Crew RJ
Morello W
Canetta P
Radhakrishnan J
Martino J
Liu Q
Chung WK
Espinoza A
Luo Y
Wei WQ
Feng Q
Weng C
Fang Y
Kullo IJ
Naderian M
Limdi N
Irvin MR
Tiwari H
Mohan S
Rao M
Dube GK
Chaudhary NS
GutiƩrrez OM
Judd SE
Cushman M
Lange LA
Lange EM
Bivona DL
Verbitsky M
Winkler CA
Kopp JB
Santoriello D
Batal I
Pinheiro SVB
Oliveira EA
Simoes E Silva AC
Pisani I
Fiaccadori E
Lin F
Gesualdo L
Amoroso A
Ghiggeri GM
D'Agati VD
Magistroni R
Kenny EE
Loos RJF
Montini G
Hildebrandt F
Paul DS
Petrovski S
Goldstein DB
Kretzler M
Gbadegesin R
Gharavi AG
Kiryluk K
Sampson MG
Pollak MR
Sanna-Cherchi S
Source :
Nature communications [Nat Commun] 2023 Nov 30; Vol. 14 (1), pp. 7836. Date of Electronic Publication: 2023 Nov 30.
Publication Year :
2023

Abstract

African Americans have a significantly higher risk of developing chronic kidney disease, especially focal segmental glomerulosclerosis -, than European Americans. Two coding variants (G1 and G2) in the APOL1 gene play a major role in this disparity. While 13% of African Americans carry the high-risk recessive genotypes, only a fraction of these individuals develops FSGS or kidney failure, indicating the involvement of additional disease modifiers. Here, we show that the presence of the APOL1 p.N264K missense variant, when co-inherited with the G2 APOL1 risk allele, substantially reduces the penetrance of the G1G2 and G2G2 high-risk genotypes by rendering these genotypes low-risk. These results align with prior functional evidence showing that the p.N264K variant reduces the toxicity of the APOL1 high-risk alleles. These findings have important implications for our understanding of the mechanisms of APOL1-associated nephropathy, as well as for the clinical management of individuals with high-risk genotypes that include the G2 allele.<br /> (© 2023. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
14
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
38036523
Full Text :
https://doi.org/10.1038/s41467-023-43020-9